Feedback

FEEDBACK

We value your feedback. Take a moment to tell us how we're doing.

Share your feedback
Marijuana Rescheduling Hearings: What Employers Need to Know – Webinar Recap - Workforce QA
Square Boxes aligned in a pattern Square Boxes aligned in a pattern

Marijuana Rescheduling Hearings: What Employers Need to Know – Webinar Recap

As discussions surrounding marijuana policy continue to evolve, employers are left with important questions about compliance, workplace safety, and the future of drug testing programs. During WorkforceQA’s recent webinar, “Marijuana Rescheduling Hearings: What Employers Need to Know,” WorkforceQA Regulatory Compliance Advisor and Director of Regulatory Affairs Dr. Donna Smith provided an in-depth analysis of the recently concluded DEA marijuana rescheduling hearings and what employers should be watching next.

Although the hearings have ended, the regulatory process is far from over. The testimony presented highlighted ongoing scientific, legal, and workplace safety concerns that could influence future federal policy. For employers, especially those with safety-sensitive positions or Department of Transportation (DOT)-regulated employees, understanding these developments is essential.

A Look at the DEA Marijuana Rescheduling Hearings

The DEA’s marijuana rescheduling hearings examined whether marijuana should be reclassified under the Controlled Substances Act. Throughout the proceedings, experts presented varying perspectives on marijuana’s medical use, scientific evidence, product consistency, and regulatory oversight.
Dr. Smith explained that while the hearings explored whether marijuana should be moved to a different schedule, many important questions remain unanswered. Topics such as standardized dosing, quality control, FDA oversight, and the scientific evidence supporting medical use were central themes throughout the testimony.
The hearings underscored the complexity of balancing evolving public policy with the need to maintain workplace safety and regulatory consistency.

What Could This Mean for Employers?

One of the biggest takeaways from the webinar was that nothing changes immediately for workplace drug testing programs.

Even if marijuana is ultimately rescheduled, employers will continue to have responsibilities under existing federal and state laws. Organizations should avoid making policy changes based solely on speculation and instead monitor regulatory developments as they occur.

Dr. Smith emphasized several areas employers should continue to evaluate:

  • Maintaining clear, well-communicated drug and alcohol policies.
  • Reviewing procedures for addressing workplace impairment.
  • Understanding the differences between state legalization laws and federal regulations.
  • Ensuring supervisors are trained to recognize and appropriately respond to reasonable suspicion situations.
  • Staying informed about future federal guidance before modifying testing programs.

DOT-Regulated Employers Should Stay the Course

For DOT-regulated employers, one message was especially clear: current federal requirements remain unchanged.

DOT drug and alcohol testing regulations continue to prohibit marijuana use regardless of state legalization or medical marijuana laws. Employees performing safety-sensitive functions remain subject to existing testing requirements, and employers must continue following all applicable DOT regulations unless federal agencies formally announce changes.

Dr. Smith reminded attendees that regulatory decisions involving marijuana scheduling do not automatically alter DOT testing rules or employer obligations.

Science, Safety, and Regulatory Oversight

The webinar also explored broader questions surrounding marijuana as medicine. Testimony presented during the hearings raised important considerations regarding:

  • Clinical evidence supporting medical use.
  • Product consistency and manufacturing standards.
  • Appropriate regulatory oversight.
  • Public health and workplace safety implications.

These discussions reinforce the need for employers to continue relying on evidence-based policies rather than assumptions or media headlines.

Preparing for What's Next

Key Takeaway

The DEA marijuana rescheduling hearings represent an important milestone in the ongoing national conversation about marijuana policy—but they are not the final word. As Dr. Donna Smith emphasized throughout the webinar, employers should remain focused on compliance, workplace safety, and regulatory awareness rather than reacting to speculation.

For both DOT-regulated and non-DOT employers, the best approach is to stay informed, maintain clear workplace expectations, and continue following current federal requirements until official regulatory changes are announced.

Missed the live webinar? Watch the on-demand recording of “Marijuana Rescheduling Hearings: What Employers Need to Know” to hear Dr. Donna Smith’s expert analysis of the hearings, key testimony, and what employers should continue monitoring as the regulatory landscape evolves.

WorkforceQA remains committed to helping organizations navigate changing regulations with confidence through trusted compliance expertise, workplace drug testing solutions, and ongoing regulatory education.

Stay Ahead of Regulatory Change with WorkforceQA

As workplace regulations continue to evolve, having a trusted compliance partner can make all the difference. Whether you’re navigating changes to marijuana laws, managing DOT compliance, or strengthening your hiring and workplace safety programs, WorkforceQA provides the expertise and technology to help you stay compliant and protect your workforce.

Simplify Workforce Screening with One Secure Platform

WorkforceQA’s all-in-one workforce screening platform streamlines every stage of the employee lifecycle by bringing your compliance programs together in one secure, easy-to-manage solution. Instead of juggling multiple vendors and disconnected systems, organizations can manage workforce screening, occupational health, and compliance from a single platform.

Our comprehensive services include:

With WorkforceQA, you gain more than a screening provider—you gain a compliance partner backed by decades of regulatory expertise and a commitment to helping organizations maintain safe, compliant workplaces.

Ready to Strengthen Your Workforce Compliance Program?

Whether you’re evaluating your current drug and alcohol testing program, updating workplace policies, or looking for a more efficient way to manage workforce screening, WorkforceQA is here to help.

Contact our team today to learn how our integrated platform and regulatory experts can simplify compliance, reduce administrative burden, and support your organization’s hiring and workforce safety initiatives.

Request a demo to see how WorkforceQA can help you manage all your workforce screening needs—from pre-employment through ongoing compliance—all from one secure platform.